Stone X Group Inc. Eli Lilly & CO Transaction History

Stone X Group Inc.

$2.06 Trillion
Q2 2025

A detailed history of Stone X Group Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Stone X Group Inc. holds 11,028 shares of LLY stock, worth $9.04 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

11,028

Previous 8,214 34.26%

Holding current value

$9.04 Million

Previous $6.78 Billion 26.72%

% of portfolio

0.42%

Previous 2.77%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$713.71 - $898.95 $2.01 Million - $2.53 Million	2,814 Added 34.26%	11,028 $8.6 Billion
Q1 2025 Aug 13, 2025	BUY	$725.72 - $929.72 $166,189 - $212,905	229 Added 2.87%	8,214 $6.78 Billion
Q4 2024 Aug 13, 2025	BUY	$727.2 - $932.06 $1.09 Million - $1.4 Million	1,504 Added 23.21%	7,985 $6.16 Billion
Q3 2024 Aug 13, 2025	BUY	$772.14 - $960.02 $360,589 - $448,329	467 Added 7.77%	6,481 $5.74 Billion
Q2 2024 Aug 13, 2025	BUY	$724.87 - $909.04 $4.36 Million - $5.47 Million	6,014 New	6,014 $5.44 Billion
Q1 2024 Aug 13, 2025	BUY	$592.2 - $792.28 $45,599 - $61,005	77 Added 1.29%	6,064 $4.72 Billion
Q4 2023 Aug 13, 2025	BUY	$525.19 - $619.13 $3.14 Million - $3.71 Million	5,987 New	5,987 $3.49 Billion
Q3 2023 Aug 13, 2025	BUY	$434.7 - $599.3 $28,690 - $39,553	66 Added 1.11%	6,008 $3.23 Billion
Q2 2023 Aug 13, 2025	BUY	$350.74 - $468.98 $2.08 Million - $2.79 Million	5,942 New	5,942 $2.79 Billion
Q1 2023 Aug 13, 2025	SELL	$310.63 - $364.82 $40,071 - $47,061	-129 Reduced 2.23%	5,656 $1.94 Billion
Q4 2022 Aug 13, 2025	BUY	$321.55 - $374.67 $1.86 Million - $2.17 Million	5,785 New	5,785 $2.12 Billion
Q3 2022 Aug 13, 2025	BUY	$296.48 - $337.87 $11,562 - $13,176	39 Added 0.67%	5,878 $1.9 Billion
Q3 2022 Nov 08, 2022	BUY	$296.48 - $337.87 $34,095 - $38,855	115 Added 2.0%	5,878 $1.9 Million
Q2 2022 Aug 13, 2025	SELL	$278.73 - $327.27 $230,230 - $270,325	-826 Reduced 12.39%	5,839 $1.89 Billion
Q2 2022 Jul 27, 2022	BUY	$278.73 - $327.27 $1.61 Million - $1.89 Million	5,763 New	5,763 $1.87 Million
Q1 2022 Aug 13, 2025	BUY	$234.69 - $291.66 $1.56 Million - $1.94 Million	6,665 New	6,665 $1.91 Billion
Q1 2022 May 11, 2022	SELL	$234.69 - $291.66 $1.35 Million - $1.68 Million	-5,759 Closed	0 $0
Q4 2021 Aug 13, 2025	BUY	$224.85 - $279.04 $1.29 Million - $1.61 Million	5,759 New	5,759 $1.59 Million
Q4 2021 Feb 10, 2022	BUY	$224.85 - $279.04 $36,425 - $45,204	162 Added 2.89%	5,759 $1.59 Million
Q3 2021 Oct 20, 2021	SELL	$221.6 - $272.71 $98,833 - $121,628	-446 Reduced 7.38%	5,597 $1.29 Million
Q2 2021 Aug 06, 2021	BUY	$180.55 - $233.54 $244,645 - $316,446	1,355 Added 28.9%	6,043 $1.39 Million
Q1 2021 Jun 23, 2021	BUY	$164.32 - $212.72 $6,244 - $8,083	38 Added 0.82%	4,688 $875,000
Q4 2020 Feb 03, 2021	BUY	$130.46 - $172.63 $36,137 - $47,818	277 Added 6.33%	4,650 $785,000
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $85,538 - $98,941	-585 Reduced 11.8%	4,373 $647,000
Q2 2020 Aug 12, 2020	BUY	$136.42 - $164.18 $9,003 - $10,835	66 Added 1.35%	4,958 $814,000
Q1 2020 Apr 30, 2020	BUY	$119.05 - $147.35 $67,739 - $83,842	569 Added 13.16%	4,892 $678,000
Q4 2019 Jan 24, 2020	BUY	$106.92 - $132.43 $6,735 - $8,343	63 Added 1.48%	4,323 $568,000
Q3 2019 Nov 12, 2019	BUY	$106.79 - $116.16 $454,925 - $494,841	4,260 New	4,260 $476,000

Others Institutions Holding LLY

# of Institutions

4,448

Shares Held

780M

Call Options Held

16.5M

Put Options Held

12.2M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $779B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stone X Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Stone X Group Inc. with notifications on news.

Account